Prime Therapeutics

Prime Therapeutics is a privately held American pharmacy benefit manager (PBM) headquartered in Eagan, Minnesota. It was formed in the late 1990s by a group of Blue Cross and Blue Shield plans that wanted a PBM aligned with their own interests rather than an outside vendor, and it remains owned collectively by those health plans. That ownership structure is central to its identity: Prime positions itself as a PBM built "by health plans, for health plans," with the stated aim of lowering drug costs for members and plan sponsors rather than maximizing PBM margin. Prime's core business is pharmacy benefit management for health plans, employers and government programs. Its services span claims processing and network management, formulary and utilization management, clinical programs, rebate and drug-spend analytics, and member support. Alongside the traditional PBM functions, Prime operates a specialty pharmacy business that dispenses high-cost specialty medications and provides the patient support, adherence and clinical monitoring that those therapies require. It also offers clinical and care-management services intended to improve medication safety and outcomes while controlling cost. Because it is owned by Blue Cross and Blue Shield plans, Prime's client base is heavily weighted toward the Blue system, and its scale reflects the combined membership of its owners. The company has grown both organically and through acquisitions and partnerships that extended its specialty pharmacy and clinical capabilities. It competes with the large national PBMs — among them CVS Caremark, Express Scripts and OptumRx — and differentiates itself on transparency, alignment with plan sponsors and its not-for-profit-adjacent ownership model. Prime is not a public company and does not report quarterly earnings; financial details are limited. Its leadership and operations are concentrated in Minnesota, with additional sites across the United States. The company is best understood as a health-plan-owned PBM and specialty pharmacy platform serving Blue plans and their members.

Prime Therapeutics was established in the late 1990s by a group of Blue Cross and Blue Shield plans seeking a pharmacy benefit manager that would serve their interests directly. Rather than contracting with an independent PBM, the plans pooled their pharmacy spend into a jointly owned company, giving them control over formulary decisions, network contracts and clinical programs. This cooperative ownership model has remained the defining feature of the company. Over the following two decades Prime expanded from core claims processing and network management into clinical programs, drug-spend analytics and specialty pharmacy. Specialty pharmacy became an increasingly important part of the business as high-cost biologic and specialty medications grew as a share of total drug spend; Prime built out dispensing, patient support and adherence services for those therapies. The company also developed utilization-management and care-management capabilities aimed at improving outcomes and safety while containing cost for plan sponsors. Prime's growth has been tied to the membership of its owner plans and to acquisitions and partnerships that broadened its specialty and clinical capabilities. It has consistently positioned itself in contrast to the large national PBMs, emphasizing transparency and alignment with plan sponsors. The company remains privately held by its member plans, is headquartered in Eagan, Minnesota, and serves health plans, employers and government programs across the United States.

• Founded in the late 1990s by a group of Blue Cross and Blue Shield plans as a jointly owned PBM.

• Expanded into specialty pharmacy and clinical programs as specialty drug spending grew.

A health-plan-owned PBM positioned as an aligned, transparent alternative to the large national PBMs.

• Pharmacy benefit management

  Claims processing, network management, formulary and utilization management, and rebate administration for health plans and employers.

• Specialty pharmacy

  Dispensing and clinical support for high-cost specialty medications.

• Clinical programs

  Medication therapy management, adherence and care-management services.

• 2026

  Florida sues Prime Therapeutics and Express Scripts over alleged drug price fixing

  Florida Attorney General James Uthmeier filed a lawsuit alleging that Prime Therapeutics and Express Scripts entered into an illegal agreement to fix prices on otherwise affordable drugs. The suit cites a December 2019 collaboration in which Prime adopted Express Scripts' lower reimbursement rates. The filing characterizes this arrangement as an illegal price-fixing agreement affecting drugs that would otherwise be affordable.

  Source

Read more

1. 1Prime Therapeutics official websiteprimetherapeutics.com
2. 2Florida sues Prime Therapeutics and Express Scripts over alleged drug price fixingwctv.tv
3. 3Florida AG sues Express Scripts and Prime Therapeutics over reimbursement cutswftv.com
4. 4Prime Therapeutics Debuts its MedSelect™ Medical Drug Listprnewswire.com
5. 5Prime Therapeutics introduces HighTouchRx™ pharmacist outreach program using both medical and pharmacy data to help maximize savingsprnewswire.com
6. 6Prime Therapeutics Introduces Real Time Benefit Check Solution with DrFirstprnewswire.com